Identity
- Security key
- 18924
- Ticker
- MXCT
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2019-12-05
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- MXCT
Detail
Enriched 2026-08-14 20:47
- Market cap
- $136,044,523.44
- Shares outstanding (class)
- 107,121,672
- Shares outstanding (weighted)
- 107,121,672
- SIC
- 8731 SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
- Employees
- 91
- Location
- ROCKVILLE, MD
- Homepage
- https://www.maxcyte.com
- Description
MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.